Parabilis Medicines, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
Craig Tendler, a Director of Parabilis Medicines, Inc., received 20,294 shares of common stock on August 22, 2026.
NASDAQ
Ra Capital Management, L.P. and 4 others reported changes in beneficial ownership of Parabilis Medicines, Inc. common stock on July 20, 2026.
NASDAQ
SEC Form 4 filing reveals significant stock transactions by Guy Levy and associated Soleus entities on June 11, 2026.